
CONMED Corporation CNMD
$ 36.8
0.38%
Annual report 2025
added 02-17-2026
CONMED Corporation Interest Expense 2011-2026 | CNMD
Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.Includes:
- Interest on bank loans
- Interest on corporate bonds
- Interest on leases
- Interest on credit lines and overdrafts
High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.
Low interest expenses with high profits are a sign of financial stability.
Annual Interest Expense CONMED Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 31.1 M | 37.3 M | 39.8 M | 28.9 M | 35.5 M | 44.1 M | 42.7 M | 20.7 M | 18.2 M | 15.4 M | 6.03 M | 6.11 M | 5.61 M | 5.73 M | 6.68 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 44.1 M | 5.61 M | 22.9 M |
Quarterly Interest Expense CONMED Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.61 M | 7.82 M | 8.29 M | 9.25 M | 9.59 M | 9.59 M | 10 M | 10 M | 10.3 M | - | 8.54 M | 5.93 M | 5 M | - | 8.14 M | 9.42 M | 10.4 M | - | 11.9 M | 11.4 M | 9.59 M | - | 11.2 M | 11.8 M | 9.37 M | - | 5.21 M | 5.09 M | 4.82 M | - | 4.81 M | 4.4 M | 4.12 M | - | 3.86 M | 3.76 M | 3.83 M | - | 1.5 M | 1.49 M | 1.46 M | - | 1.54 M | 1.57 M | 1.46 M | - | 1.38 M | 1.38 M | 1.37 M | - | 1.34 M | 1.55 M | 1.44 M | - | 1.67 M | 1.71 M | 1.8 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 11.9 M | 1.34 M | 5.73 M |
Interest Expense of other stocks in the Medical devices industry
| Issuer | Interest Expense | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
AdaptHealth Corp.
AHCO
|
-274 K | $ 13.17 | 0.46 % | $ 1.78 B | ||
|
BIOLASE
BIOL
|
-1 K | - | -13.19 % | $ 166 K | ||
|
Allied Healthcare Products
AHPI
|
191 K | - | 3.58 % | $ 2.21 M | ||
|
Eargo
EAR
|
549 K | - | - | $ 10.2 M | ||
|
Delcath Systems
DCTH
|
-70 K | $ 10.8 | 4.05 % | $ 387 M | ||
|
Apollo Endosurgery
APEN
|
4.67 M | - | - | $ 475 M | ||
|
Second Sight Medical Products
EYES
|
947 K | - | -0.97 % | $ 54.4 M | ||
|
Electromed
ELMD
|
78 K | $ 25.6 | -0.43 % | $ 216 M | ||
|
Avinger
AVGR
|
1.72 M | - | -20.74 % | $ 369 K | ||
|
Axonics Modulation Technologies
AXNX
|
-2.43 M | - | - | $ 3.31 B | ||
|
EDAP TMS S.A.
EDAP
|
232 K | $ 3.47 | 4.52 % | $ 130 M | ||
|
Aziyo Biologics
AZYO
|
-2.76 M | - | 1.37 % | $ 20.5 M | ||
|
BioSig Technologies
BSGM
|
1.6 M | - | 37.08 % | $ 85.7 M | ||
|
Helius Medical Technologies
HSDT
|
46.9 K | $ 2.12 | 3.92 % | $ 1.29 M | ||
|
Inspire Medical Systems
INSP
|
-2.66 M | $ 56.7 | 1.0 % | $ 1.67 B | ||
|
Conformis
CFMS
|
2.02 M | - | - | $ 16.4 M | ||
|
LivaNova PLC
LIVN
|
664 K | $ 61.0 | 1.5 % | $ 3.33 B | ||
|
ClearPoint Neuro
CLPT
|
-146 K | $ 11.37 | 1.7 % | $ 322 M | ||
|
Cardiovascular Systems
CSII
|
1.63 M | - | 0.15 % | $ 844 M | ||
|
Invacare Corporation
IVC
|
28.5 M | - | - | $ 24.7 M | ||
|
Dynatronics Corporation
DYNT
|
410 K | - | 14.99 % | $ 929 K | ||
|
Neovasc
NVCN
|
133 K | - | - | $ 111 M | ||
|
OrthoPediatrics Corp.
KIDS
|
6.05 M | $ 15.65 | 3.92 % | $ 367 M | ||
|
Butterfly Network
BFLY
|
-13 K | $ 5.4 | 12.97 % | $ 1.14 B | ||
|
Sintx Technologies
SINT
|
31 K | $ 2.41 | 14.22 % | $ 6.68 M | ||
|
Globus Medical
GMED
|
3.41 M | $ 91.34 | 1.29 % | $ 12.4 B | ||
|
TransMedics Group
TMDX
|
3.87 M | $ 100.01 | -0.77 % | $ 3.4 B | ||
|
NanoVibronix
NAOV
|
135 K | - | - | $ 1.08 M | ||
|
Integer Holdings Corporation
ITGR
|
-53.2 M | $ 84.03 | -5.06 % | $ 2.92 B | ||
|
Edwards Lifesciences Corporation
EW
|
7.2 M | $ 83.98 | 0.57 % | $ 49.1 B | ||
|
Tandem Diabetes Care
TNDM
|
-13 M | $ 19.41 | -0.61 % | $ 1.32 B | ||
|
LENSAR
LNSR
|
636 K | $ 5.61 | 7.27 % | $ 67.1 M | ||
|
Pulmonx Corporation
LUNG
|
790 K | $ 1.35 | 5.47 % | $ 54.9 M | ||
|
MiMedx Group
MDXG
|
-558 K | $ 3.68 | 9.52 % | $ 544 M | ||
|
Myomo
MYO
|
-668 K | $ 0.9 | 4.16 % | $ 37.7 M |